Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome. [PDF]
Kang SM +9 more
europepmc +1 more source
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation. [PDF]
Gordon LB +10 more
europepmc +1 more source
Lonafarnib Clinical Trials Demonstrate Uncoupling of the Muscle-Bone Unit in Hutchinson-Gilford Progeria Syndrome. [PDF]
Kreienkamp RJ +8 more
europepmc +1 more source
Author Correction: Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1. [PDF]
Zhang N +10 more
europepmc +1 more source
Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson-Gilford Progeria Syndrome. [PDF]
Lederer EM +5 more
europepmc +1 more source
Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies. [PDF]
Hartinger R +4 more
europepmc +1 more source
Generation of Nonintegrative-Induced Pluripotent Stem Cells in Hutchinson-Gilford Progeria Syndrome: Enhancing Aging Research. [PDF]
Kadiwala J, Shakur R.
europepmc +1 more source
Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. [PDF]
Díez-Díez M +12 more
europepmc +1 more source
National survey of Hutchinson-Gilford progeria syndrome and progeroid laminopathy in Japan. [PDF]
Okawa Y +20 more
europepmc +1 more source
Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome. [PDF]
Murtada SI +10 more
europepmc +1 more source

